You can read more about the medical classification in our article GLP-1 agonists: approval and off-label use
It has been shown to have antioxidant and anti-inflammatory properties that help defend the skin from toxic free radicals and environmental damage
They work by stimulating pancreatic beta cells to secrete insulin more rapidly and effectively after meals, thereby controlling postprandial hyperglycemia
The USADA states: There appears to be no legal basis for selling BPC-157 as a drug, food, or a dietary supplement, and the Food and Drug Administration (FDA) confirmed there is also no legal basis for compounding pharmacies to use BPC-157 in compounded medications
de Laat V, Topal H, Spotbeen X, Talebi A, Dehairs J, Idkowiak J, et al
Instead of focusing on restrictions, GPs can encourage patients to focus on habits that nurture gut and metabolic health: Fibre-rich foods (whole grains, legumes, vegetables): promote bowel regularity and microbial diversity Hydration: supports constipation management and reduces nausea Nutrient-dense, whole foods: prioritise quality over quantity, especially when appetite is low GLP-1 receptor agonists provide a unique window to build lasting healthy habits